31.53 -0.13 (-0.41%)
FRX
| Trade FRX now with |
|
Stock Details
Last Trade:31.53 Change:-0.13 (-0.41%) Prev Close:31.66 Open: 31.91 Days Range:31.35 – 31.92 52 Week Range: 28.47 - 40.52 Volume:1400458 P/E: 7.96EPS:3.96
View AllRecent Alerts 02/09/12
Recent Alert on 02/08/12 at 6:50am
Forest Labs (FRX), Gedeon Richter Report Cariprazine Phase III Reuslts In-Line with Two Prior Studies
Forest Labs (FRX), Gedeon Richter Report Cariprazine Phase III Reuslts In-Line with Two Prior Studies
Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc. today announced preliminary top-line results from a Phase III clinical trial of cariprazine (RGH-188), an investigational antipsychotic agent, in patients with acute mania associated with... Read More
Recent Alert on 02/08/12 at 6:50am
Forest Labs (FRX), Gedeon Richter Report Cariprazine Phase III Reuslts In-Line with Two Prior Studies
Forest Labs (FRX), Gedeon Richter Report Cariprazine Phase III Reuslts In-Line with Two Prior Studies
Recent Alert on 01/18/12 at 12:04pm
Cantor Fitzgerald Raises Price Target on Forest Laboratories (FRX) on Q3 Upside and New FY12 Guidance
Cantor Fitzgerald Raises Price Target on Forest Laboratories (FRX) on Q3 Upside and New FY12 Guidance
Recent Alert on 01/18/12 at 8:33am
Needham & Company Maintains a 'Hold' on Forest Laboratories (FRX); Strength of Established Products Drives EPS Beat as New Launches Begin Gaining Traction
Needham & Company Maintains a 'Hold' on Forest Laboratories (FRX); Strength of Established Products Drives EPS Beat as New Launches Begin Gaining Traction
Recent Alert on 01/17/12 at 8:03am
Forest Laboratories, Inc. (FRX) Tops Q3 EPS by 3c; Raises FY12 Outlook
Forest Laboratories, Inc. (FRX) Tops Q3 EPS by 3c; Raises FY12 Outlook
View AllRecent Press Releases
Press Release on 02/09/12 at 8:00am
Synergy Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference
Synergy Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference
Press Release on 02/08/12 at 8:00am
Synergy Pharmaceuticals Engages The Trout Group for Investor Relations Services
Synergy Pharmaceuticals Engages The Trout Group for Investor Relations Services